Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
President Trump has posted a new announcement on Truth Social, the social media platform. He wrote:
“Trump Announces Dramatic Drop in Ozempic Price:”
How Will Trump’s Statement Affect the Stock Market?
This latest post has the potential to affect the stock market. That’s because Trump’s claim of a dramatic Ozempic price drop could pressure shares of Novo Nordisk and Eli Lilly, as investors may price in lower margins and future pricing power for GLP‑1 drugs, at least in the short term. Pharmacy and PBM‑exposed players like CVS Health might see a modest boost if investors expect higher prescription volumes and improved affordability to increase traffic and script counts. Broader healthcare and biotech ETFs (XLV, VHT, IBB) could experience short‑term volatility as markets reassess drug pricing risk and policy uncertainty, but any lasting impact would depend on whether the pricing change is real, sizable, and durable.
Here are some of the stocks that might be affected:
CVS Health Corp ((CVS)),
Eli Lilly And Company ((LLY)),
Novo Nordisk ((NVO)),
Health Care Select Sector SPDR Fund ((XLV)),
Vanguard Health Care ETF ((VHT)),
iShares Biotechnology ETF ((IBB)).